GUIDANCE DOCUMENT
Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products Guidance for Industry December 2012
- Docket Number:
- FDA-2012-D-1135
- Issued by:
-
Guidance Issuing OfficeCenter for Drug Evaluation and Research
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2012-D-1135.